Shree Pacetronix Ltd vs Transgene Biotek Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Shree Pacetronix Ltd is ₹ 158.1 as of 23 Oct 15:30 . The P/E Ratio of Shree Pacetronix Ltd changed from 77.1 on March 2021 to 10.9 on March 2026 . This represents a CAGR of -27.82% over 6 yearsThe P/E Ratio of Transgene Biotek Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Shree Pacetronix Ltd changed from ₹ 4.16 crore on March 2021 to ₹ 34.33 crore on March 2026 . This represents a CAGR of 42.16% over 6 yearsThe Market Cap of Transgene Biotek Ltd changed from ₹ 34.7 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Shree Pacetronix Ltd for the Jun '26 is ₹ 4.92 crore as compare to the Mar '26 revenue of ₹ 5.41 crore. This represent the decline of -9.06% The revenue of Transgene Biotek Ltd for the Jun '26 is ₹ 0.06 crore as compare to the Mar '26 revenue of ₹ 0.2 crore. This represent the decline of -70% The ebitda of Shree Pacetronix Ltd for the Jun '26 is ₹ 1.21 crore as compare to the Mar '26 ebitda of ₹ 1.68 crore. This represent the decline of -27.98% The ebitda of Transgene Biotek Ltd for the Jun '26 is ₹ -0.06 crore as compare to the Mar '26 ebitda of ₹ -0.13 crore. This represent the decline of -53.85% The net profit of Shree Pacetronix Ltd changed from ₹ 0.37 crore to ₹ 0.76 crore over 9 quarters. This represents a CAGR of 37.70% The net profit of Transgene Biotek Ltd changed from ₹ 0.2 crore to ₹ -0.39 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Shree Pacetronix Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Transgene Biotek Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Shree Pacetronix Ltd

Shree Pacetronix Limited, a leading manufacturer / exporter of Pacemakers, was incorporated in January 1988 as a Private Limited Company and converted into a Public Limited Company in 1993.
It has a plant at Pithampur, Madhya Pradesh with installed capacity to produce 4800 pacemakers per annum. Pacemakers are used to treat patients suffering mainly from heart conditions, such as heart failure and arrhythmias.
These devices are implanted under patient's chest by cardiologist to deal with various indications and used for the treatment of heart medical conditions.
Innovations such as longer-lasting batteries, advanced remote monitoring capabilities, and next-generation leadless and MRI-safe pacemakers are key pillars of the R&D agenda.
These developments not only improve clinical outcomes but also align with evolving patient needs and healthcare provider expectations, allowing to maintain a competitive edge in the rapidly advancing pacemaker industry.

About Transgene Biotek Ltd

Founded in March 1990 by Dr. Koteswara Rao, Transgene Biotek Limited was one of the first Biotechnology companies in India.
Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc.
The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.

FAQs for the comparison of Shree Pacetronix Ltd and Transgene Biotek Ltd

Which company has a larger market capitalization, Shree Pacetronix Ltd or Transgene Biotek Ltd?

Market cap of Shree Pacetronix Ltd is 59 Cr while Market cap of Transgene Biotek Ltd is 19 Cr

What are the key factors driving the stock performance of Shree Pacetronix Ltd and Transgene Biotek Ltd?

The stock performance of Shree Pacetronix Ltd and Transgene Biotek Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Shree Pacetronix Ltd and Transgene Biotek Ltd?

As of October 25, 2026, the Shree Pacetronix Ltd stock price is INR ₹158.1. On the other hand, Transgene Biotek Ltd stock price is INR ₹2.57.

How do dividend payouts of Shree Pacetronix Ltd and Transgene Biotek Ltd compare?

To compare the dividend payouts of Shree Pacetronix Ltd and Transgene Biotek Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.